One test, three viruses: new device aims to simplify screening
NCT ID NCT06082336
Summary
This study is testing a new medical device called MagIA IBC, which is designed to screen for three major infections—HIV, hepatitis B, and hepatitis C—from a single, small blood sample. The goal is to see how accurate and reliable this combined test is compared to standard methods. The study is enrolling 252 adults who are known or suspected to have one of these infections to validate the test's performance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMBINED POINT OF CARE DIAGNOSTIC OF HIV, HBV AND HCV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de Perpignan - Equipe Mobile Hépatites
RECRUITINGPerpignan, 66000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Européen de Marseille
COMPLETEDMarseille, France, 13003, France
Conditions
Explore the condition pages connected to this study.